Drreddys Laboratories | RDY - Current Liabilities


Drreddys Laboratories reported INR1.76B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
ANI Pharmaceuticals USD 278.11M 7.56M Dec/2025
Aurora Cannabis CAD 124.12M 32.76M Sep/2025
Bayer EUR 32.58B 3.63B Dec/2025
Canopy Growth CAD 81.1M 17.56M Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Drreddys Laboratories INR 1.76B 62.5M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Lonza CHF 3.58B 970M Dec/2024
Novartis USD 32B 286M Sep/2025
Pacira USD 120.59M 13.51M Dec/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
Prestige Brands USD 139.56M 4.95M Dec/2025
Richter Gedeon HUF 182.16B 6.92B Sep/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025